摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[[(3R)-1,4-dioxaspiro[4.5]decan-3-yl]methyl]guanidine

中文名称
——
中文别名
——
英文名称
2-[[(3R)-1,4-dioxaspiro[4.5]decan-3-yl]methyl]guanidine
英文别名
——
2-[[(3R)-1,4-dioxaspiro[4.5]decan-3-yl]methyl]guanidine化学式
CAS
——
化学式
C10H19N3O2
mdl
——
分子量
213.28
InChiKey
HPBNRIOWIXYZFK-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    82.9
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • 1,5-Substituted indol-2-yl amide derivatives
    申请人:Nettekoven Matthias
    公开号:US20070123515A1
    公开(公告)日:2007-05-31
    The present invention relates to compounds of formula I wherein R 1 to R 4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    本发明涉及式I的化合物,其中R1至R4和G如描述和索赔中定义的,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与H3受体调节相关的疾病。
  • INDOL-2-YL-PIPERAZIN-1-YL-METHANONE DERIVATIVES
    申请人:Nettekoven Matthias
    公开号:US20080188484A1
    公开(公告)日:2008-08-07
    The present invention relates to compounds of formula I wherein A and R 1 to R 4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    本发明涉及公式I的化合物,其中A和R1至R4如描述和声明中所定义,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与H3受体调节相关的疾病。
  • BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES
    申请人:Mohr Peter
    公开号:US20090029976A1
    公开(公告)日:2009-01-29
    The present invention relates to compounds of formula I wherein X, A and R 1 to R 4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    本发明涉及公式I的化合物,其中X,A和R1至R4如描述和索赔中所定义,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与H3受体调节相关的疾病。
  • 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
    申请人:DeAngelis Alan
    公开号:US20060058393A1
    公开(公告)日:2006-03-16
    The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR modulators to treat or inhibit the progression of, for example, dyslipidemia.
    这项发明涉及4-((苯氧烷基)硫基)-苯氧乙酸及其类似物,含有它们的组合物,以及将它们用作PPAR调节剂来治疗或抑制例如脂质代谢异常的进展的方法。
  • 1,1-Dioxo-thiomorpholinyl indolyl methanone derivatives
    申请人:Nettekoven Matthias
    公开号:US20070123526A1
    公开(公告)日:2007-05-31
    The present invention relates to compounds of formula I wherein R 1 , R 2 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
    本发明涉及式I的化合物,其中R1、R2和G如描述和索赔中定义的,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与H3受体调节相关的疾病。
查看更多